Inovio Pharmaceuticals Inc Earnings

The next earnings date for Inovio Pharmaceuticals Inc has not yet been scheduled.

Analyst Estimates of Inovio Pharmaceuticals Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Inovio Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/12/2025	Before Market	$-0.51	31.08%
03/04/2025	After Market	---	---
11/07/2024	Before Market	$-0.89	22.61%
08/08/2024	After Market	$-1.19	-8.18%
05/13/2024	After Market	$-1.31	-31.00%
03/06/2024	After Market	$-1.12	11.81%
11/09/2023	After Market	$-0.13	0.00%
08/09/2023	After Market	$-0.13	7.14%
05/10/2023	After Market	$-0.16	-14.29%
03/01/2023	After Market	$-0.21	-23.53%
11/08/2022	After Market	$-0.15	50.00%
08/09/2022	After Market	$-0.46	-48.39%
05/10/2022	After Market	$-0.36	-5.88%
03/01/2022	After Market	$-0.50	-56.25%
11/09/2021	After Market	$-0.29	12.12%
08/09/2021	After Market	$-0.39	-56.00%
05/10/2021	After Market	$-0.27	-50.00%
03/01/2021	After Market	$-0.14	36.36%
11/09/2020	After Market	$0.11	157.89%
08/10/2020	After Market	$-0.85	-400.00%
05/11/2020	After Market	$-0.22	0.00%
03/12/2020	After Market	$-0.38	-58.33%
11/12/2019	After Market	$-0.25	3.85%
08/08/2019	After Market	$-0.30	-11.11%
05/09/2019	After Market	$-0.30	-15.38%
03/12/2019	After Market	$-0.35	-25.00%
11/08/2018	After Market	$-0.27	10.00%
08/07/2018	After Market	$-0.07	68.18%
05/09/2018	After Market	$-0.36	-227.27%
03/14/2018	After Market	$-0.23	23.33%
11/08/2017	After Market	$-0.39	-56.00%
08/08/2017	After Market	$-0.13	31.58%
05/10/2017	After Market	$-0.31	0.00%
03/15/2017	After Market	$-0.35	-16.67%
11/09/2016	Before Market	$-0.28	-3.70%
08/08/2016	Before Market	$-0.26	-23.81%
05/09/2016	Before Market	$-0.11	21.43%
03/14/2016	Before Market	$-0.26	-30.00%
11/09/2015	Before Market	$0.07	75.00%
08/10/2015	Before Market	$-0.10	23.08%
05/11/2015	Before Market	$-0.17	-54.55%
03/16/2015	Before Market	$-0.12	-20.00%
11/10/2014	Before Market	$-0.12	14.29%
08/11/2014	---	$-0.18	5.26%
05/12/2014	---	$-0.20	-25.00%
03/17/2014	---	$-0.28	-100.00%
11/12/2013	---	$-0.64	-540.00%
08/09/2013	---	$-0.24	-71.43%
05/10/2013	---	$-0.24	-41.18%
03/18/2013	---	$-0.02	89.61%
11/07/2012	---	$-0.20	-42.86%
08/09/2012	---	$-0.12	29.41%
05/09/2012	---	$-0.24	-33.33%
03/15/2012	---	$-0.16	20.00%
11/07/2011	---	$-0.16	-23.08%
08/08/2011	---	$-0.08	57.89%
05/11/2011	---	$-0.08	46.67%
03/17/2011	---	$-0.28	-86.67%
11/15/2010	---	$-0.04	63.64%
08/16/2010	---	$-0.28	-250.00%
05/17/2010	---	$-0.08	55.56%
03/29/2010	---	$-0.28	-75.00%
11/16/2009	---	$-0.12	40.00%
08/19/2009	---	$-0.76	-216.67%
05/15/2009	---	$-3.78	---
03/31/2009	---	$-0.32	-14.29%
11/07/2008	---	$-0.20	47.37%
08/07/2008	---	$-0.36	-28.57%
05/09/2008	---	$-0.28	36.36%
03/17/2008	---	$-0.08	82.98%
11/08/2007	---	$-0.44	-12.82%
08/08/2007	---	$-0.44	-10.00%
05/09/2007	---	$-0.44	-18.92%
03/16/2007	---	$-0.56	-30.23%
11/08/2006	---	$-0.44	-10.00%
08/08/2006	---	$-0.40	-11.11%
05/09/2006	---	$-0.36	18.18%
03/16/2006	---	$-2.40	-275.00%
11/09/2005	---	$-0.64	25.58%
08/09/2005	---	$-0.44	52.17%
05/10/2005	---	$-0.88	0.00%
03/15/2005	---	$-0.84	-2.44%
11/15/2004	---	$-0.80	-53.85%
08/09/2004	---	$-1.61	---
05/15/2004	---	$-0.40	37.50%
03/30/2004	---	$-0.48	0.00%
11/12/2003	---	$-29.51	---
07/16/2003	---	$-5.31	---
03/31/2003	---	$-14.75	---

More About Inovio Pharmaceuticals Inc

Website

https://www.inovio.com

Country

USA

Full Time Employees

134

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the University of Pennsylvania, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

“Inovio Pharmaceuticals Inc Earnings” Can Refer to the Inovio Pharmaceuticals Inc Earnings Date

Some people say “Inovio Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Inovio Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Inovio Pharmaceuticals Inc Stock on the Earnings Date

If you own Inovio Pharmaceuticals Inc stock (INO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Inovio Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Inovio Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Owning Inovio Pharmaceuticals Inc Options on the Earnings Date

If you own Inovio Pharmaceuticals Inc options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

In addition, the extrinsic values of Inovio Pharmaceuticals Inc options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Inovio Pharmaceuticals Inc options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.

This makes sense considering that prices are often more volatile on earnings dates for Inovio Pharmaceuticals Inc. That potential volatility is a key factor that affects the premium cost of owning options.

Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Inovio Pharmaceuticals Inc options often go down. This is sometimes referred to as volatility crush.

Learning More Inovio Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Inovio Pharmaceuticals Inc earnings or anything else related to the stock market.